Home / Virtual products: Br / Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags
- ID
- 39362811000001101
- Therapeutic Moiety
- Brexucabtagene autoleucel
- Name
- Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Date of name applicability
- 11 Oct 2022
- Previous name
- Autologous anti-CD19-transduced CD3+ cells 40million-200million cells/68ml dispersion for infusion bags
- Basis of previous name
- Other
- Reason for name change
- New approved generic name available
- Prescribing status
- Valid as a prescribable product
- Dose form
- Discrete
- Unit dose form size
- 68.000
- Unit dose form units
- ml
- Unit dose unit of measure
- bag
- Ingredients
- Brexucabtagene autoleucel
- Form & Route
- dispersioninfusion.intravenous
- Drug formulations
- Dispersion for infusion
- Drug route
- Intravenous
- Control drug
- No Controlled Drug Status